A critical breakthrough in cancer research is occurring with the use of mini-antibodies to reactivate mutated p53. This vital tumor inhibitor protein is frequently inactivated in many types of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research